Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03468179 · ClinicalTrials.gov registry record · NA
Oatmeal Effect on N-acyl-phosphatidylethanolamines
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03468179 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 10 participants.
The verdict
NCT03468179, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
N-acyl-phosphatidylethanolamine (NAPEs) and their active metabolites, N-acyl-ethanolamides (NAEs) are lipid satiety factors that are normally biosynthesized in the intestinal tract in response to food intake. Reduced levels of NAPEs and NAEs have been found in obese individuals, and increasing plasma NAPE and NAEs levels may be beneficial to obese individuals trying to lose weight or to keep off weight gain after losing weight. We have found that oatmeal has large amounts of NAPEs, and based on previous mouse studies, we hypothesize that a single dose of dietary oatmeal is sufficient to double plasma NAE from baseline, possibly inducing satiety and increasing basal metabolic rate. To test this hypothesis, we will feed volunteers a single weight-based serving of oatmeal while monitoring its effects on serum glucose, NAPE and NAE levels as well as on subjective satiety.
Interventions
- DIETARY_SUPPLEMENT Oatmeal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-10-07 |
| Est. Completion | 2018-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03468179
The ClinicalTrials.gov registry entry for NCT03468179 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oatmeal is the first listed.
NCT03468179 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03468179 about?
NCT03468179 is a clinical study titled "Oatmeal Effect on N-acyl-phosphatidylethanolamines". N-acyl-phosphatidylethanolamine (NAPEs) and their active metabolites, N-acyl-ethanolamides (NAEs) are lipid satiety factors that are normally biosynthesized in the intestinal tract in response to food intake. Reduced levels of NAPEs and NAEs have been found in obese individuals, and increasing plasm...
What is the current status of trial NCT03468179?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-10-07. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT03468179?
The interventions under investigation include: Oatmeal (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03468179?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.